Chronic diseases, such as heart disease, diabetes, chronic respiratory conditions, and autoimmune disorders, are some of the leading causes of death and disability worldwide. As these conditions continue to place a growing burden on healthcare systems, the need for more effective treatments is pressing. Biopharmaceuticals, which include biologic drugs derived from living organisms, are poised